A Delaware Supreme Court ruling has opened the door to Benlate lawsuits in the home state of the DuPont Co., producer of the controversial fungicide whose alleged ability to cause birth defects has resulted in a flood of lawsuits against the world-class chemical company.
The state’s highest court May 25 reversed a Superior Court judge’s finding that a lawsuit brought on behalf of six children born in England, Scotland, Wales and New Zealand should be heard in courts in those countries. The children suffered from severe eye defects that were attributed to their mothers’ exposure to Benlate.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
